Prudential Financial Inc Chimerix Inc Transaction History

Prudential Financial Inc

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 11, 2023	SELL	$1.1 - $1.54 $522 - $731	-475 Reduced 1.36%	34,400 $41,000
Q1 2023 May 12, 2023	SELL	$1.19 - $2.09 $41,888 - $73,568	-35,200 Reduced 50.23%	34,875 $43,000
Q4 2022 Feb 14, 2023	BUY	$1.67 - $2.35 $26,152 - $36,801	15,660 Added 28.78%	70,075 $0
Q3 2022 Nov 04, 2022	BUY	$1.81 - $2.76 $98,491 - $150,185	54,415 New	54,415 $105,000
Q4 2019 Feb 11, 2020	SELL	$1.3 - $2.72 $17,384 - $36,374	-13,373 Reduced 55.4%	10,765 $21,000
Q2 2019 Aug 08, 2019	BUY	$2.05 - $4.32 $49,482 - $104,276	24,138 New	24,138 $0

36.8M

72.2K

169K

Ticker CMRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 87,622,896
Market Cap $85M
Description
Chimerix, Inc., a biopharmaceutical company, develops medicines to enhance the lives of patients living with serious diseases. The company's approved product is TEMBEXA (brincidofovir), a lipid conjugate through inhibition of viral DNA synthesis that is developed as a medical countermeasure for smallpox. Its clinical stage development programs i...

Get notified when there are updates to the investment portfolio of Prudential Financial Inc, based on Form 13F filings with the SEC.

Stay updated on Prudential Financial Inc with notifications on news.